Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly.
about
Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoproteinConditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.Renal Drug Transporters and Drug Interactions.IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats.P-glycoprotein in sheep liver and small intestine: gene expression and transport efflux activity.
P2860
Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Morphological and functional c ...... ethasone-induced hepatomegaly.
@en
Morphological and functional c ...... ethasone-induced hepatomegaly.
@nl
type
label
Morphological and functional c ...... ethasone-induced hepatomegaly.
@en
Morphological and functional c ...... ethasone-induced hepatomegaly.
@nl
prefLabel
Morphological and functional c ...... ethasone-induced hepatomegaly.
@en
Morphological and functional c ...... ethasone-induced hepatomegaly.
@nl
P2093
P50
P1476
Morphological and functional c ...... ethasone-induced hepatomegaly.
@en
P2093
Frantisek Staud
Jan Osterreicher
Jirina Martinkova
Jolana Cermanova
Leos Fuksa
Lucie Mundlova
Pavla Pokorna
P2860
P304
P356
10.1111/J.1440-1681.2007.04558.X
P577
2007-04-01T00:00:00Z